Murata vs. Cypress for Blood Pressure Device Components: 3 Scenarios From a Cost Controller

I've managed component procurement for connected health devices for six years. In that time, I've tracked over $180,000 in spending, audited nine supplier projects, and watched a couple of "strategic cost savings" turn into certified budget disasters. This article is about one recurring decision: when you're building a blood pressure monitoring device, do you integrate a bare wireless chip like the Cypress CYW43438 into your own board, or buy Murata's integrated module and pair it with their ultrasonic sensor platform and 18650 battery cells?

The honest answer is: it depends. Three scenarios. Let me walk you through them, because the way I see it, most procurement advice fails precisely because it pretends there's a universal answer.

Why "Cheaper Per Unit" Is the Wrong Starting Point

First, let's clear up a misconception that keeps costing companies money. People assume expensive vendors deliver better quality. Actually, vendors who deliver consistency can charge more—the causation runs the other way. What you're buying with Murata's health-device components isn't just performance. It's predictability.

And predictability has a price.

In Q2 2024, I ran a full comparison for a blood pressure monitor design across 8 vendors. The bare Cypress chip approach quoted $2.40 less per unit in BOM. Simple conclusion, right? Then I built a Total Cost of Ownership spreadsheet—engineering hours, antenna tuning, certification retests, re-spin risk—and the "cheaper" path came out to $0.90 more per unit at 200,000 units before even factoring delay risk. That's the number nobody quotes in the initial pitch.

There is a version where the bare chip wins. And there's a version where you should pay the premium happily. They're different scenarios.

Scenario A: Hard Deadline, Enterprise Contract Pressure

You know this feeling. A pilot program with a major enterprise client—think HPE-scale account—needs a working prototype in eight weeks. The sales team made commitments. The contract has a penalty clause. And your RF engineer is still reading the chipset reference design.

In this situation, don't be a hero. Choose the integrated Murata wireless module (the one with the Cypress core inside), the Murata ultrasonic sensor, and a power solution that fits your mechanical design. For a portable home BP monitoring system, that's typically a couple of Murata 18650 lithium-ion cells in the base station.

The premium per unit? Maybe $3.50. The cost of missing an enterprise contract? Much, much larger.

In March 2024, we paid $400 in expedited shipping and engineering sample fees to hit a demo deadline for a potential 10,000-unit client. A colleague called it waste. That demo alone led to a first-year contract worth $38,000. Simple math.

That's the certainty premium in action. It's not luxury. It's the cheapest risk mitigation you'll ever buy.

Scenario B: Large Manufacturer, In-House RF Expertise

Flip the context. You're a 400-person medical device company with a real RF lab, a regulatory affairs team that knows FDA 510(k) filing by heart, and 18 months of runway before launch. Volumes are projected at one million units over two years.

Here, I'd seriously consider using the bare Cypress chip instead of Murata's pre-built wireless module. Engineering integration costs might amortize down to $0.30 per unit at that volume. The per-unit savings becomes real money. The module premium could be a strategic mistake.

But—and I've learned this the hard way—discount your own estimates by a factor of two. My 2023 audit of nine procurement projects showed in-house integration estimates ran 87% over budget on engineering hours on average. And every project that planned for "no re-spin" had at least one re-spin. Not because the engineers were bad. RF is genuinely uncertain.

If you choose this path, budget a re-spin into the timeline and calendar. That said, I'll note we've only seen this work well at scale with mature teams—it's not a strategy for a team that's still building its RF competence.

Scenario C: Medical Certification and Regulatory Approval Required

Blood pressure monitors are not lifestyle gadgets. If you're heading toward FDA 510(k) or CE marking, component selection changes entirely.

The certification body doesn't care about your BOM cost. They care about evidence that your device is safe and accurate. This is where Murata's advantages go well beyond the part itself. Their ultrasonic sensor platform comes with years of characterization data. Their 18650 cells have documented safety test results. Their wireless modules carry pre-certified radio approvals in multiple jurisdictions.

Reusing that packaging of evidence in your submission can shave months off regulatory timelines.

Per my cost tracking across six regulatory submission projects between 2021 and 2024, using mature, pre-certified components shortened average submission preparation by four to seven months compared with novel components lacking existing evidence. In a market where competitors are launching faster, those months beat any per-unit saving on paper.

The assumption is that certified parts are just more expensive. The reality is that non-certified parts cost you time, and time is your scarcest budget line.

How to Determine Which Scenario You're In

Back when this mattered for our own product line, I had about two hours to decide before a supplier commitment deadline. The sales contract was already signed, and normally I would have run a full cost model with sensitivity ranges. There was no time. I used the diagnostic below, and it's been useful ever since:

1. How many days until your first critical milestone? Under 90 days? You're in Scenario A. Over 400 days? Scenario B becomes viable.
2. What does your RF team actually look like? If you can't confidently name the person who owns antenna tuning and radio certification, you're in Scenario A. If you have a named expert with prior certifications and shipping products, you can consider Scenario B.
3. Is this a medical device by regulatory definition? If yes, you're at least partly in Scenario C regardless of team size. Evidence requirements don't bend for engineering budgets.

Honestly, I should have pushed back on that two-hour deadline. But with the CEO waiting, I made the call with incomplete information. I went with Murata's integrated solution, and even after choosing it, I kept second-guessing. What if the ultrasonic sensor accuracy didn't align with our algorithms? What if the 18650 cell's cycle life missed the marketing spec? I didn't fully relax until the first validation samples arrived—and matched the datasheets.

That's the emotional side of procurement that never makes it into vendor brochures. Accountability for component reliability is nerve-wracking. The certified, integrated, predictable choice buys something measurable: peace of mind. It's not a line item, but it affects every subsequent decision.

Bottom Line: The Certainty Question

The "Cypress vs. Murata" framing is a false contrast if you treat it as chip versus module. The real question is whether your situation justifies paying for delivery certainty.

Murata's wireless modules incorporate Cypress chips—the CYW43438 is sitting in a drawer in my office right now. Buying the module isn't rejecting Cypress. It's paying Murata to handle RF layout, antenna tuning, and certification paperwork so your engineers can focus on blood-pressure algorithms and user experience instead.

For a blood pressure monitoring product—where accuracy directly affects clinical trust—deciding in favor of certainty is defensible at almost any price point. I'd rather explain to a CFO why we paid $3 more per unit than explain why our certification timeline slipped five months. Good luck with that meeting.

Component pricing as of March 2025. Verify current rates, lead times, and availability with Murata, Infineon (which now owns Cypress), and authorized distributors. Supply chains shift fast, and I've learned not to trust static quotes.